Validation of AclarusDx™, a blood-based transcriptomic signature for the diagnosis of Alzheimer's disease.
Fehlbaum-Beurdeley P, Sol O, Désiré L, Touchon J, Dantoine T, Vercelletto M, Gabelle A, Jarrige AC, Haddad R, Lemarié JC, Zhou W, Hampel H, Einstein R, Vellas B; EHTAD/002 study group.
Fehlbaum-Beurdeley P, et al.
J Alzheimers Dis. 2012;32(1):169-81. doi: 10.3233/JAD-2012-120637.
J Alzheimers Dis. 2012.
PMID: 22785402